Clinical Trial Update: A Study of Nemolizumab for the Treatment of Adults With Systemic Sclerosis [Phase 2]

View source ↗

Summary

This is a Phase 2 clinical trial update evaluating nemolizumab for adults with systemic sclerosis; the study is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Systemic Sclerosis

Drugs mentioned

• Nemolizumab (nemolizumab)

Snippet

Sponsor: Galderma R&D | Conditions: Systemic Sclerosis | Phase 2 | Status: RECRUITING